Want to see ICCC full AI Analyst Report?
Immucell (ICCC) Stock Forecast & Price Target
ICCC Analyst Ratings
There are no analyst ratings in the last 3 months.
ICCC Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | $10.50→$12 | buy | 15.72%Upside | Upgraded | 10/14/26 | ||
| Google Biotechnology | TipRanks - Google | $11→$12 | buy | 15.72%Upside | Reiterated | 10/14/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | $10→$11 | hold | 6.08%Upside | Reiterated | 10/14/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | $11→$11.50 | hold | 10.90%Upside | Reiterated | 10/14/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | $11→$12 | buy | 15.72%Upside | Reiterated | 10/14/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | $11→$12 | buy | 15.72%Upside | Reiterated | 10/14/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | BuyUpgraded$10.50→$12 | 10/14/26 | 15.72%Upside | ||
| Google BiotechnologyTipRanks - Google | BuyReiterated$11→$12 | 10/14/26 | 15.72%Upside | ||
| Anthropic BiotechnologyTipRanks - Anthropic | HoldReiterated$10→$11 | 10/14/26 | 6.08%Upside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldReiterated$11→$11.50 | 10/14/26 | 10.90%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | BuyReiterated$11→$12 | 10/14/26 | 15.72%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | BuyReiterated$11→$12 | 10/14/26 | 15.72%Upside |
Best Analysts Covering Immucell
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.70% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +4.10% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +4.10% per trade.
ICCC Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, ICCC has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ICCC average Analyst price target in the past 3 months is ―.
ICCC Financial Forecast
ICCC Earnings Forecast
Next quarter’s earnings estimate for ICCC is $0.20 with a range of ― to ―. The previous quarter’s EPS was $0.20. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ICCC Sales Forecast
Next quarter’s sales forecast for ICCC is $7.19M with a range of ― to ―. The previous quarter’s sales results were $7.19M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
